## Immunopathology of Rheumatoid Arthritis: Autoantibodies and Genetics ### Autoantibodies in RA **Key Point:** Rheumatoid factor and anti-CCP antibodies are the hallmark serologic markers of RA, but they arise from systemic immune dysregulation, not primarily from synovial fluid. ### Rheumatoid Factor vs. Anti-CCP | Feature | Rheumatoid Factor (RF) | Anti-CCP | |---------|------------------------|----------| | Target | Fc portion of IgG | Citrullinated proteins | | Prevalence in RA | ~80% (seropositive RA) | ~70% | | Specificity for RA | ~85% | ~95% (higher) | | Erosive disease prediction | Moderate | Excellent | | Presence before symptoms | Can be present years before | Can precede disease by years | | Isotypes | IgM, IgG, IgA | Primarily IgG | **High-Yield:** Anti-CCP antibodies are MORE specific and predictive of erosive disease than rheumatoid factor. Patients with both RF+ and anti-CCP+ have the worst prognosis. ### Site of Immune Activation 1. **Primary Site: Synovial Tissue (NOT synovial fluid)** - Immune activation occurs in the synovial membrane - CD4+ T cells recognize citrullinated antigens presented by HLA-DR - B cells differentiate into plasma cells producing RF and anti-CCP - Activated macrophages and fibroblasts produce cytokines 2. **Systemic Manifestations** - Autoantibodies (RF, anti-CCP) are produced systemically by bone marrow plasma cells - These circulate and form immune complexes in serum - Complexes deposit in joints, but also in other tissues (rheumatoid nodules, vasculitis) - Synovial fluid contains immune complexes that have already formed systemically **Warning:** A common misconception is that the synovial fluid is the PRIMARY site of immune activation. In reality, the synovial TISSUE (membrane) is where T cell activation and B cell differentiation occur. The synovial fluid is a secondary site where immune complexes accumulate. ### HLA and Genetic Susceptibility **Key Point:** HLA-DR4 (DRB1*04) and HLA-DR3 (DRB1*03) alleles confer susceptibility through the "shared epitope" hypothesis. - **Shared Epitope:** A conserved amino acid sequence (QKRAA or similar) in the third hypervariable region of HLA-DRβ1 chain - **Mechanism:** This epitope preferentially presents citrullinated peptides to T cells - **Citrullination:** Post-translational modification of arginine to citrulline in proteins like fibrinogen, vimentin, collagen - **Molecular Mimicry:** Bacterial antigens (e.g., Porphyromonas gingivalis) may have epitopes similar to citrullinated self-antigens **Mnemonic:** **SHEAR** — Shared Epitope, HLA-DR4/DR3, Erosive disease, Anti-CCP, Rheumatoid factor.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.